News for Vera Therapeutics, Inc. (VERA)

Summary Vera Therapeutics Inc (VERA), a late clinical-stage biotechnology company, announced on July 10, 2025, that its Compensation Committee has granted induc

Vera Therapeutics (VERA) announces inducement grants for 15 new employees under the Nasdaq Listing Rule 5635(c)(4). Grants include options to purchase 1

There’s a current of optimism in the air as Wall Street’s stock markets climb back to record levels, with the S&P 500 hitting an all-time high yesterday. In this environment, it’s tempting to just start buying, but a smart investor will still take a moment to pause, check the signals, and find the right stock. Few market signals come in clearer than insider buys, and for good reason. These corporate officers, residents of C-suites and Boards of Directors, know the inside workings of their compan

You may be concerned about the recent declines in AI stocks such as NVDA.

Vera Therapeutics (VERA) has observed a significant bearish trend with a surge in put trading activity, specifically, 1,935 put contracts have been exchanged, t

Market Analysis by covering: Sanofi ADR, Kymera Therapeutics Inc, Vera Therapeutics Inc, Rapport Therapeutics Inc. Read 's Market Analysis on Investing.com

Vera Therapeutics (VERA) experienced a notable increase in bullish options trading, with 6,061 call contracts exchanged, quadrupling the usual volume. This acti

Summary On June 9, 2025, Vera Therapeutics Inc (VERA), a biotechnology company based in Brisbane, California, announced the granting of inducement awards to sev

BRISBANE, Calif., June 09, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. ( VERA) today announced that on June 3, 2025, the Compensation Committee granted i

**media[649901]**

Weekly Market Highlights An eventful week in the stock market saw a notable 14.3% decline in Tesla (TSLA) shares following a public clash between Elon Musk

U.S. stocks traded higher midway through trading, with the Nasdaq Composite jumping more than 1% on Friday. The Dow traded up 1.05% to 42,765.32 while the NASD...

U.S. stocks traded higher this morning, with the Dow Jones jumping more than 500 points on Friday. Following the market opening Friday, the Dow traded up 1.29%...

U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining around 0.2% on Monday. The Dow traded down 0.49% to 42,064.07 while the NASD...

Virtual event with Key Opinion Leaders to discuss cell therapy landscape and shortcomings of CAR-T therapies set for May 28, 2025 HOUSTON, May 19, 2025 (GLO

Vera Therapeutics (VERA) is on the cusp of a pivotal moment as it anticipates the primary endpoint findings from the key atacicept ORIGIN 3 trial. If these resu

On track to announce the primary endpoint results from the atacicept pivotal Phase 3 ORIGIN trial in IgA Nephropathy (IgAN) in 2Q 2025; planning for Biologics L

Vera Therapeutics (VERA) has recently garnered attention following a significant development from HC Wainwright & Co. On May 5, 2025, the prominent investment f

Summary Protagonist Therapeutics Inc (PTGX) has announced that an abstract detailing the results of their Phase 3 study on Rusfertide for the treatment of polyc